These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9425951)

  • 21. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient.
    Jeantet D; Chemin I; Mandrand B; Zoulim F; Trepo C; Kay A
    Hepatology; 2002 May; 35(5):1215-24. PubMed ID: 11981772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?
    Bréchot C; Thiers V; Kremsdorf D; Nalpas B; Pol S; Paterlini-Bréchot P
    Hepatology; 2001 Jul; 34(1):194-203. PubMed ID: 11431751
    [No Abstract]   [Full Text] [Related]  

  • 23. Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H.
    Erhardt A; Göbel T; Ludwig A; Lau GK; Marcellin P; van Bömmel F; Heinzel-Pleines U; Adams O; Häussinger D
    J Med Virol; 2009 Oct; 81(10):1716-20. PubMed ID: 19697400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and significance of hepatitis B virus surface gene variant circulating among 'antiHBc only' individuals in Eastern India.
    Banerjee A; Chandra PK; Datta S; Biswas A; Bhattacharya P; Chakraborty S; Chakrabarti S; Bhattacharya SK; Chakravarty R
    J Clin Virol; 2007 Dec; 40(4):312-7. PubMed ID: 17997353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance for hepatitis B surface antigen mutants.
    Coleman PF
    J Med Virol; 2006; 78 Suppl 1():S56-8. PubMed ID: 16622879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.
    Kumar M; Sarin SK
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):465-95. PubMed ID: 19072396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants.
    Chong-Jin O; Wei Ning C; Shiuan K; Gek Keow L
    J Infect Dis; 1999 Jan; 179(1):259-63. PubMed ID: 9841851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosis.
    Colledge D; Soppe S; Yuen L; Selleck L; Walsh R; Locarnini S; Warner N
    Virology; 2017 Jan; 501():70-78. PubMed ID: 27871021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus.
    Ogura Y; Kurosaki M; Asahina Y; Enomoto N; Marumo F; Sato C
    J Infect Dis; 1999 Nov; 180(5):1444-51. PubMed ID: 10515802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan.
    Hsu HY; Chang MH; Liaw SH; Ni YH; Chen HL
    Hepatology; 1999 Nov; 30(5):1312-7. PubMed ID: 10534356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.
    Koo YX; Tan DS; Tan BH; Quek R; Tao M; Lim ST
    J Clin Oncol; 2009 May; 27(15):2570-1; author reply 2571-2. PubMed ID: 19364951
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
    Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically.
    Song BC; Kim SH; Kim H; Ying YH; Kim HJ; Kim YJ; Yoon JH; Lee HS; Cha CY; Kook YH; Kim BJ
    J Med Virol; 2005 Jun; 76(2):194-202. PubMed ID: 15834881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetic diversity of hepatitis B virus in Kenya.
    Mwangi J; Nganga Z; Songok E; Kinyua J; Lagat N; Muriuki J; Lihana R; Khamadi S; Osman S; Lwembe R; Kiptoo M; Mwau M; Chirchir R; Mpoke S; Nyamongo J; Okoth F; Yamada R; Kageyama S; Ichimura H
    Intervirology; 2008; 51(6):417-21. PubMed ID: 19258721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
    Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
    Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus carriers; natural course, diagnostic approach and treatment.
    Ranjan P; Aggarwal R
    Trop Gastroenterol; 2005; 26(2):58-65. PubMed ID: 16225046
    [No Abstract]   [Full Text] [Related]  

  • 37. Transmission of "a" determinant variants of hepatitis B virus in immunized babies born to HBsAg carrier mothers.
    Velu V; Saravanan S; Nandakumar S; Dhevahi E; Shankar EM; Murugavel KG; Kumarasamy T; Thyagarajan SP
    Jpn J Infect Dis; 2008 Jan; 61(1):73-6. PubMed ID: 18219140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
    Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses.
    De Mitri MS; Morsica G; Cassini R; Bagaglio S; Andreone P; Bianchi G; Loggi E; Bernardi M
    Arch Virol; 2007 Feb; 152(2):395-404. PubMed ID: 16953307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional analysis of HBV genomes from patients with fulminant hepatitis.
    Sterneck M; Kalinina T; Günther S; Fischer L; Santantonio T; Greten H; Will H
    Hepatology; 1998 Nov; 28(5):1390-7. PubMed ID: 9794926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.